Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
31,672
-820
-3% -$21.4K 0.02% 147
2026
Q1
$912K Buy
32,492
+958
+3% +$25.5K 0.03% 118
2025
Q4
$785K Buy
31,534
+319
+1% +$8.04K 0.02% 124
2025
Q3
$795K Sell
31,215
-194
-0.6% -$4.79K 0.03% 122
2025
Q2
$761K Buy
31,409
+3,540
+13% +$82.6K 0.03% 117
2025
Q1
$706K Buy
27,869
+780
+3% +$20.4K 0.03% 106
2024
Q4
$719K Sell
27,089
-3,026
-10% -$82.1K 0.03% 102
2024
Q3
$872K Buy
30,115
+1,088
+4% +$31.7K 0.03% 97
2024
Q2
$812K Sell
29,027
-637
-2% -$17.5K 0.03% 98
2024
Q1
$823K Buy
29,664
+10,025
+51% +$278K 0.04% 91
2023
Q4
$651K Hold
19,639
0.04% 90
2023
Q3
$651K Sell
19,639
-3,665
-16% -$130K 0.04% 90
2023
Q2
$855K Buy
23,304
+4,485
+24% +$175K 0.05% 82
2023
Q1
$768K Buy
18,819
+212
+1% +$9.16K 0.05% 85
2022
Q4
$953K Sell
18,607
-94
-0.5% -$4.51K 0.07% 68
2022
Q3
$818K Buy
18,701
+356
+2% +$17.3K 0.07% 67
2022
Q2
$962K Buy
18,345
+4,719
+35% +$240K 0.07% 65
2022
Q1
$705K Sell
13,626
-11
-0.1% -$571 0.06% 77
2021
Q4
$805K Sell
13,637
-673
-5% -$33.3K 0.07% 67
2021
Q3
$615K Buy
14,310
+3
+0% +$133 0.06% 79
2021
Q2
$560K Buy
14,307
+307
+2% +$11.9K 0.06% 81
2021
Q1
$507K Buy
14,000
+3
+0% +$107 0.08% 72
2020
Q4
$515K Buy
+13,997
New +$513K 0.1% 56

Other funds holding PFE

Foster Group's PFE Position: Q2 2026 in Review

Foster Group reduced its Pfizer (PFE) stake by 2.5% in Q2 2026, selling an estimated $21.4K and leaving 31,672 shares worth $763K. The position accounts for 0.02% of the portfolio, ranked #147.

Foster Group first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $962K in Q2 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Foster Group held 31,672 shares of Pfizer worth $763K as of Q2 2026.
  • Foster Group sold 820 Pfizer shares in Q2 2026, an estimated $21.4K.
  • Pfizer made up 0.02% of Foster Group's portfolio in Q2 2026, its #147 holding.
  • Foster Group first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Foster Group's Pfizer position peaked at $962K in Q2 2022.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.